Indication
Prevention of surgery-induced bleeding in Glanzmann's thrombasthenia
Glanzmann's thrombasthenia is a rare, inherited hematologic disorder of primary hemostasis characterized by quantitative or qualitative deficiencies in the platelet membrane integrin glycoprotein IIb/IIIa (aIIbß3) complex. Read more about Prevention of surgery-induced bleeding in Glanzmann's thrombasthenia
1 drugs 1 manufacturers
Drugs that treat it
Common Prevention of surgery-induced bleeding in Glanzmann's thrombasthenia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGlanzmann's thrombasthenia is a rare, inherited hematologic disorder of primary hemostasis characterized by quantitative or qualitative deficiencies in the platelet membrane integrin glycoprotein IIb/IIIa (aIIbß3) complex.
Because this receptor complex is essential for fibrinogen binding and normal platelet aggregation, affected individuals experience impaired clot formation despite maintaining typical platelet counts and morphology.
Prevention of surgery-induced bleeding in this population targets the acute perioperative risk of severe, uncontrolled hemorrhage triggered by invasive surgical interventions.
In this clinical setting, proactive hemostatic support aims to achieve adequate vascular sealing and prevent potentially life-threatening operative blood loss.
- nih.gov
Glanzmann's thrombasthenia is a rare, inherited hematologic disorder of primary hemostasis characterized by quantitative or qualitative deficiencies in the platelet membrane integrin glycoprotein IIb/IIIa (αIIbβ3) complex In this clinical setting, proactive hemostatic support aims to achieve adequate vascular sealing and prevent potentially life-threatening operative blood loss
- nih.gov
Glanzmann's thrombasthenia is a rare, inherited hematologic disorder of primary hemostasis characterized by quantitative or qualitative deficiencies in the platelet membrane integrin glycoprotein IIb/IIIa (αIIbβ3) complex Because this receptor complex is essential for fibrinogen binding and normal platelet aggregation, affected individuals experience impaired clot formation despite maintaining typical platelet counts and morphology
- nih.gov
Because this receptor complex is essential for fibrinogen binding and normal platelet aggregation, affected individuals experience impaired clot formation despite maintaining typical platelet counts and morphology Prevention of surgery-induced bleeding in this population targets the acute perioperative risk of severe, uncontrolled hemorrhage triggered by invasive surgical interventions In this clinical setting, proactive hemostatic support aims to achieve adequate vascular sealing and prevent po...
- nih.gov
Because this receptor complex is essential for fibrinogen binding and normal platelet aggregation, affected individuals experience impaired clot formation despite maintaining typical platelet counts and morphology Prevention of surgery-induced bleeding in this population targets the acute perioperative risk of severe, uncontrolled hemorrhage triggered by invasive surgical interventions
- nih.gov
Prevention of surgery-induced bleeding in this population targets the acute perioperative risk of severe, uncontrolled hemorrhage triggered by invasive surgical interventions
Personalize your experience
Follow Prevention of surgery-induced bleeding in Glanzmann's thrombasthenia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.